Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-METFORMIN 850MG TABLET Resolved 2020-10-01 2020-10-22 125455
TEVA-METFORMIN 850MG TABLET Resolved 2023-01-19 2023-04-28 181594
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-16 2024-09-19 228143
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340

Showing 181 to 200 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-CAPTOPRIL 25MG TABLET Discontinued 2025-05-28 2025-05-28 258556
TEVA-CARBAMAZEPINE 200MG TABLET Discontinued 2017-06-27 2017-06-27 14052
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
TEVA-CEPHALEXIN 250MG TABLET Discontinued 2020-10-08 2020-10-09 125982
TEVA-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Discontinued 2025-05-28 2025-05-28 258759
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
TEVA-CLARITHROMYCIN 500MG TABLET Discontinued 2020-06-11 2020-06-11 117526
TEVA-CLARITHROMYCIN 250MG TABLET Discontinued 2020-06-11 2020-06-11 117529
TEVA-CLOBETASOL 0.05% LOTION Discontinued 2025-04-25 2025-04-25 255815
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64923
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64926
TEVA-CLONAZEPAM 2MG TABLET Discontinued 2018-10-19 2018-10-19 64929
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-25 2019-10-26 97248
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-31 2019-11-01 97589
TEVA-DEFERASIROX 125MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103791

Showing 181 to 200 of 435